MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis

Citations Over TimeTop 19% of 2015 papers

Abstract

An important unresolved clinical issue is to distinguish hepatitis B virus (HBV) infection caused chronic hepatitis and their corresponding liver cirrhosis (LC). Recent research suggests that circulating microRNAs are useful biomarkers for a wide array of diseases. We analyzed microRNA profiles in the plasmas of a total of 495 chronic hepatitis B (CHB) patients, LC patients and healthy donors and identified 10 miRNAs that were differentially expressed between CHB and LC patients. Our logistic models show that three panels of miRNAs have promising diagnostic performances in discriminating CHB from LC. Blinded tests were subsequently conducted to evaluate the diagnostic performances in clinical practice and a sensitivity of 85% and specificity of 70% have been achieved in separating CHB from LC pateints. The expression levels of some circulating miRNAs were significantly correlated with HBV DNA load and liver function, such as prothrombin activity (PTA) and levels of alanin aminotransferase (ALT), albumin (ALB) and cholinesterase (CHE). Our results provide important information for developing novel diagnostic tools for distinguishing chronic HBV hepatitis and their corresponding cirrhosis.

Related Papers

• → Role of alcohol in pathogenesis of hepatitis B virus infection(2020)48 cited
• → Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease(2003)103 cited
• → The Assessment of Liver Disease Utilizing a Panel of Liver Function Tests(2022)1 cited
• → Prevalence of hepatitis B virus infection in the Gezira State of Central Sudan(2007)37 cited
• Detection of Hepatitis B virus Markers in 587 Medical Workers(2009)